Company profile
Visirna Therapeutics company profile
Arrowhead and Vivo formed Visirna Therapeutics as a joint venture to bring four of the biotech's RNAi therapies to China. Through a licensing agreement, the company will focus on four of Arrowhead's therapies for cardiometabolic diseases.
Business identity
- Website
- https://www.visirna.com/
- Contact email
- [email protected]
- Phone number
- +86 021-6107 5030
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 51-100 employees
- Founded
- 2022-01-01, Year
Headquarters
- Headquarters
- Shaxi, Fujian, China
- Country code
- CN
- Continent
- Asia